Brainstorm Cell Therapeutics Ownership | Who Owns Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics Ownership Summary
Brainstorm Cell Therapeutics is owned by 15.20% institutional investors, 9.04% insiders, and 75.76% retail investors. Armistice capital is the largest institutional shareholder, holding 12.23% of BCLI shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.33% of its assets in Brainstorm Cell Therapeutics shares.
BCLI Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Brainstorm Cell Therapeutics | 15.20% | 9.04% | 75.76% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Armistice capital | 7.92M | 12.23% | $2.68M |
Vanguard group | 1.51M | 2.33% | $511.35K |
Geode capital management | 484.29K | 0.75% | $163.99K |
Blackrock | 386.41K | 0.60% | $130.80K |
Liberty wealth management | 340.15K | 0.53% | $115.00K |
Weaver consulting group | 234.36K | 0.36% | $79.33K |
State street | 117.26K | 0.18% | $39.69K |
Northern trust | 112.36K | 0.17% | $38.03K |
Raymond james & associates | 111.28K | 0.17% | $37.67K |
Two sigma securities | 102.02K | 0.16% | $34.53K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Armistice capital | 7.92M | 0.03% | $2.68M |
Weaver consulting group | 234.36K | 0.03% | $79.33K |
Liberty wealth management | 340.15K | 0.02% | $115.00K |
Saxony capital management | 12.95K | 0.00% | $4.38K |
Jmac enterprises | 65.43K | 0.00% | $22.15K |
Virtu financial | 49.59K | 0.00% | $17.00K |
Activest wealth management | 7.08K | 0.00% | $2.40K |
Tower research capital llc (trc) | 86.58K | 0.00% | $29.35K |
Two sigma securities | 102.02K | 0.00% | $34.53K |
Institutional & family asset management | 6.00K | 0.00% | $2.03K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Armistice capital | 7.92M | 0.03% | 7.92M |
Geode capital management | 484.29K | - | 127.24K |
Vanguard group | 1.51M | - | 109.65K |
Two sigma securities | 102.02K | 0.00% | 102.02K |
Tower research capital llc (trc) | 86.58K | 0.00% | 75.57K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Abner herrman & brock | - | - | -145.50K |
Gsa capital partners llp | - | - | -111.23K |
Blackrock | 386.41K | - | -102.90K |
Ikarian capital | - | - | -90.24K |
Kingswood wealth advisors | - | - | -81.05K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Armistice capital | 7.92M | 0.03% | 7.92M | $2.68M |
Two sigma securities | 102.02K | 0.00% | 102.02K | $34.53K |
Lpl financial | 10.05K | - | 10.05K | $3.40K |
Activest wealth management | 7.08K | 0.00% | 7.08K | $2.40K |
Northwestern mutual wealth management | 161.00 | - | 161.00 | $55.00 |
Sold Out
Holder | Change |
---|---|
Mark sheptoff financial planning | -100.00 |
Corecap advisors | -133.00 |
Bnp paribas arbitrage, snc | -364.00 |
St germain d j | -500.00 |
Cranbrook wealth management | -1.00K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 37 | -26.00% | 10,822,353 | -10.37% | 15 | 4.37% | 10 | -52.38% | 9 | - |
Jun 30, 2024 | 50 | 4.17% | 12,075,121 | 210.89% | 18 | 51.82% | 21 | 75.00% | 9 | -18.18% |
Mar 31, 2024 | 48 | -4.00% | 3,884,111 | 2.17% | 5 | 7.70% | 12 | -29.41% | 11 | -8.33% |
Dec 31, 2023 | 50 | -12.28% | 3,801,493 | -17.96% | 8 | 8.05% | 17 | -32.00% | 12 | - |
Sep 30, 2023 | 57 | -10.94% | 4,633,812 | -16.75% | 10 | 5.33% | 25 | - | 12 | -7.69% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 70.73K | 1.33% | 7.00 |
Fidelity Extended Market Index | 436.04K | 0.55% | 101.84K |
Vanguard Institutional Extnd Mkt Idx Tr | 26.73K | 0.50% | 2.00 |
Fidelity Series Total Market Index | 100.49K | 0.13% | 54.53K |
NT Ext Equity Mkt Idx Fd - L | 79.81K | 0.10% | - |
BlackRock Extended Equity Market K | 62.75K | 0.08% | -27.00 |
Fidelity Nasdaq Composite Index | 48.73K | 0.06% | - |
Fidelity Total Market Index | 47.81K | 0.06% | - |
Vanguard Instl Ttl Stck Mkt Idx Tr | 33.75K | 0.04% | - |
NT Ext Equity Mkt Idx Fd - NL | 30.05K | 0.04% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Oct 01, 2024 | Lebovits Chaim | President & CEO | Buy | $6.29K |
Sep 30, 2024 | Lebovits Chaim | President & CEO | Buy | $5.02K |
May 28, 2024 | Lebovits Chaim | President & CEO | Buy | $7.77K |
May 21, 2024 | Lebovits Chaim | President & CEO | Buy | $14.47K |
May 22, 2024 | Lebovits Chaim | President & CEO | Buy | $16.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | 1 | - |
2024 Q3 | 1 | 1 |
2024 Q2 | 11 | - |
2024 Q1 | - | - |
2023 Q3 | 1 | - |
BCLI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools